Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Lundin Mining Announces Dates of Annual Meeting of Shareholders and First Quarter 2022 Results

TORONTO, April 12, 2022 /CNW/ - (TSX: LUN; Nasdaq Stockholm: LUMI) Lundin Mining Corporation (“Lundin Mining” or the “Company”) today announces that its Annual Meeting will be held on Thursday, May 12, 2022 (the “Meeting”) at 10:00 a.m. ET via live audio webcast online at www.virtualshareholdermeeting.com/lun2022 . The Notice of Meeting, the accompanying Management Proxy Circular (the “Circular”) and related meeting

Notice to the annual general meeting in Cint Group AB (publ)

The shareholders of Cint Group AB (publ) (“Cint” or the “Company”) are hereby given notice of the annual general meeting to be held on 17 May 2022. In light of the risk of continued spread of the virus causing Covid-19, the board of directors has decided that the annual general meeting will be held without the physical presence of shareholders, proxies or external parties and that the shareholders shall have the opportunity to exercise their voting rights only by postal voting prior to the general meeting. Right to participate and notice of attendance Shareholders who wish to

Correction: DanCann Pharma A/S Announces the appointment of Louise Conradsen to accelerate growth as new subsidiary CEO of CannGros ApS

Correction: Due to minor confusion about whether Louise Conradsen was appointed as CEO of DanCann Pharma A/S, or the subsidiary CannGros ApS, the Company has chosen to correct its headline in its Company announcement, where the Company makes it clear that Louise Conradsen is appointed as CEO of the subsidiary, CannGros ApS. Jeppe Krog Rasmussen remains the CEO of DanCann Pharma A/S. The correction is adjusted from ”DanCann Pharma A/S Announces the appointment of Louise Conradsen as new Chief Executive Officer to accelerate growth of CannGros ApS” to “DanCann Pharma A/S Announces the

Nordea Bank Abp: Repurchase of own shares on 12.04.2022

Nordea Bank AbpStock exchange release – Changes in company’s own shares12.04.2022 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 12.04.2022 completed repurchases of own shares (ISIN: FI4000297767) as follows: Trading Number of Weighted average Total cost, EUR* **venue (MIC shares price / share, EUR* Code) **XSTO 670,977 9.54 6,399,671.28XHEL 564,307 9.51 5,367,575.32CEUX 452,618 9.53 4,313,615.11AQEU 44,057 9.51

Simon-Kucher & Partners welcomes Scott Sands as a Partner in the Atlanta office

With the appointment of Scott Sands, Simon-Kucher will be expanding client offerings to include expertise in sales strategy and optimization.Boston, U.S. April 2022 -- Simon-Kucher & Partners  is pleased to announce Scott Sands has been elected to the firm’s partnership in North America. This appointment is part of a strategic move to further expand offerings, expertise and growth in Sales Effectiveness. Scott’s appointment brings the total number of partners to 30 in the U.S. and 160 globally. Scott, based out of the Atlanta, GA office, will lead the

Arctic Bioscience – Mandatory notification of trade

Christer L. Valderhaug, CEO of Arctic Bioscience, has today bought 10,000 shares in Arctic Bioscience at an average price of NOK 16.954 per share. Following the transaction, Christer L. Valderhaug holds 20,000 shares and 250,000 share options in Arctic Bioscience.Please refer to the attached notification of trading for further details.  This information is subject to the disclosure requirements pursuant to Regulation EU 596/2014 (MAR) article 19 number 3 and the Norwegian Securities Trading Act § 5-12.

Conciliator submits settlement proposal for UPM Biofuels

(UPM, Helsinki, 12 April 2022 at 20:20 EEST) – Conciliator Leo Suomaa has submitted a proposal for UPM Biofuels in the collective labour negotiations with the Paperworkers’ Union. The conciliator has asked the parties to state their position on the proposal by 14 April 2022 at 10:00 EEST, which is also the deadline for the settlement proposals for UPM Pulp, UPM Specialty Papers and UPM Raflatac, given earlier by the conciliator. The conciliation for UPM Communication Papers was interrupted last weekend. "Settlement proposals have now been given to four out of five UPM businesses

Nanoform Finland Plc – Manager’s transactions – Gonçalo Andrade

Company release Nanoform Finland Plc April 12, 2022 07:05 p.m. Finnish time / 06:05 p.m. Swedish time Nanoform Finland Plc – Manager’s transactions – Gonçalo Andrade Helsinki, Finland – Manager’s transaction related to Nanoform Finland Plc’s other senior manager Gonçalo Andrade’s share subscription with stock options from option program 2/2019: Person subject to the notification requirement Name: Andrade, Goncalo Position: Other senior manager Issuer: Nanoform Finland Plc LEI: 743700JJO2NU8LBS1592 Notification type: INITIAL NOTIFICATION Reference number:

Nanoform Finland Plc – Manager’s transactions – Niklas Sandler

Company release Nanoform Finland Plc April 12, 2022 07:05 p.m. Finnish time / 06:05 p.m. Swedish time Nanoform Finland Plc – Manager’s transactions – Niklas Sandler Helsinki, Finland – Manager’s transaction related to Nanoform Finland Plc’s other senior manager Niklas Sandler’s share subscription with stock options from option program 2/2019: Person subject to the notification requirement Name: Sandler, Niklas Position: Other senior manager Issuer: Nanoform Finland Plc LEI: 743700JJO2NU8LBS1592 Notification type: INITIAL NOTIFICATION Reference number:

Pihlajalinna Plc – Acquisition of own shares on 12 April 2022

Pihlajalinna Plc           Stock Exchange Release                     12 April 2022   Pihlajalinna Plc – Acquisition of own shares on 12 April 2022   At Nasdaq Helsinki Ltd:   +------------------------+--------------+|Date | 12 April 2022|+------------------------+--------------+|Exchange transaction | Buy |+------------------------+--------------+|Share trading code | PIHLIS |+------------------------+--------------+|Amount, shares  | 4,335 |+------------------------+--------------+|Total cost, EUR

Resolutions of the Constitutive Meeting of the Board of Directors of Nanoform Finland Plc

Company release Nanoform Finland Plc April 12, 2022 07:00 p.m. Finnish time / 06:00 p.m. Swedish time Resolutions of the Constitutive Meeting of the Board of Directors of Nanoform Finland Plc Nanoform Finland Plc’s (the “Company” or “Nanoform“) Board of Directors held its constitutive meeting on April 12, 2022. The meeting elected the following persons to the Audit and Compensation Committee of the Board of Directors of the Company: Miguel Calado (chairperson), Jeanne Thoma (ordinary member) and Mads Laustsen (ordinary member). The Audit and Compensation Committee is a

Share subscriptions based on Nanoform Finland Plc’s multiple Stock Option Programs

Company release Nanoform Finland Plc April 12, 2022 07:00 p.m. Finnish time / 06:00 p.m. Swedish time Share subscriptions based on Nanoform Finland Plc’s multiple Stock Option Programs Helsinki, Finland – Between March 17 and March 31, 2022, a total of 163,500 Nanoform Finland Plc’s (the “Company” or “Nanoform“) new shares have been subscribed for with the Company’s 1/2019, 2/2019, 3/2019, 5/2019 and 1/2020 stock options programs. The entire subscription price for subscriptions made with the stock options of EUR 203,500 will be entered in the Company’s reserve for invested

Invitation to conference call and webcast presentation of Dometic’s interim report for the first quarter 2022

Dometic Group AB (publ) will publish its interim report for the first quarter 2022 at around 08.00 CEST on Thursday, April 28, 2022. On the same day at 10.00 CEST, Dometic will host a conference call and webcast to present the results. The presentation can be followed live via webcast and will also be available afterwards. The presentation will be held in English. The report and the presentation material will be available on Dometic’s website, https://www.dometicgroup.com/en/investors 

#22-130 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

#22-129 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

DanCann Pharma A/S Announces the appointment of Louise Conradsen as new Chief Executive Officer to accelerate growth of CannGros ApS

COPENHAGEN, Denmark, 12 April 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the “Company”), a Danish company powered by cannabinoids, hereby announce that the Company has recruited and appointed its new Chief Executive Officer (“CEO”), Louise Conradsen, for the subsidiary CannGros ApS (“CannGros”) to elevate CannGros to a significantly higher commercial level strengthening the product portfolio and pipeline. Louise Conradsen will start in her new function with effect from 10th May 2022.Louise Conradsen is a commercial management professional with more than eighteen years of

DanCann Pharma A/S: NOTICE OF ANNUAL GENERAL MEETING

The Board of Directors hereby convenes the annual general meeting of DanCann Pharma A/S, CVR-no. 39 42 60 05 (“Company”), to be held on Thursday, 27 April 2022 at 09:00 am (CET) at DanCann Pharma A/S’ address, Rugvænget 5, DK-6823 Ansager The agenda for the annual general meeting is as follows: 1. The chairman’s report on the activities of the Company in the past financial year 2. Adoption of the annual report for 2021 3. Application of profit or covering of loss pursuant to the adopted annual report for 2021 4. Election of members of the Board of Directors 5. Election

DanCann Pharma A/S: Independent auditor's report

Opinion We have audited the consolidated financial statements and the parent financial statements of Dancann Pharma A/S for the financial year 01.01.2021 - 31.12.2021, which comprise the income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies, for the Group as well as the Parent, and the consolidated cash flow statement. The consolidated financial statements and the parent financial statements are prepared in accordance with the Danish Financial Statements Act. In our opinion, the consolidated financial statements and

DanCann Pharma A/S publishes Annual Report 2021

COPENHAGEN, Denmark, 12 April 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the “Company”), a Danish company powered by cannabinoids, hereby announce that The Board of Directors and the Chief Executive Officer of DanCann Pharma publishes the annual report of the year 2021. The annual report is available after today's trading on the Spotlight Stock Market, and hereby available in this press release and on the website of DanCann Pharma.For more information, visit: https://www.dancann.com/investor-relations-ir/general-meetings.  Disclaimer Some statements in this release

FISKARS CORPORATION: ACQUISITION OF OWN SHARES 12.04.2022

Fiskars Corporation   Stock Exchange Release 12.04.2022 at 18:30 EET/EEST   FISKARS CORPORATION: ACQUISITION OF OWN SHARES 12.04.2022   Date 12.04.2022  Exchange transaction Buy  Share class FSKRS  Amount  5,700  Average price/share 20.3459 EURHighest price/share 20.5000 EURLowest price/share 20.1500 EURTotal price 115,971.63 EUR        The shares held by Fiskars Corporation on 12.04.2022:   FSKRS 499,563       On

Baseload Capital seeks approval from bondholders regarding certain amendments to the terms and conditions of its MSEK 500 senior secured green bonds

Baseload Capital Sweden AB (publ) (“Baseload”) today announces that it is, through a written procedure, soliciting approval from holders of its bonds (the “Bondholders”) with ISIN SE0011923267 (the “Bonds”) to make certain amendments to the terms and conditions of the Bonds.Baseload has requested that Nordic Trustee & Agency AB (publ), acting in its capacity as agent (the “Agent”) for the Bondholders, initiates a written procedure in accordance with the terms and conditions of the Bonds. The purpose of the written procedure is for the Bondholders to grant consent to certain amendments to

ABS Publishes Insights on Vessel Connectivity Technologies

(HOUSTON) The demands on vessel connectivity driven by smart, autonomous and remote-control functions are explored in the latest addition to ABS’ industry-leading series of guidance on key maritime technologies. Insights into Vessel Connectivity discusses communication technologies available and provides guidance to vessel owners, operators and system vendors in ensuring they are equipped to meet current and future demand. The publication reviews the relevant regulations and industrial standards on vessel connectivity, as well as future technology development and challenges. “The ship-

Smoltek's Nomination Committee proposes the election of two new Board members

This press release is an English version of the previously published Swedish version, which has interpretive precedence. Smoltek Nanotech Holding AB (“Smoltek”) announces that the company's Nomination Committee proposes Edvard Kälvesten and Per Zellman to be elected as new Board members at the Annual General Meeting on May 12, 2022. The proposed members are deemed to provide the Board with valuable expertise in company development as well as industrialization and commercialization of disruptive technology.Smoltek continues to develop from a research-driven company to an innovative

There are no items matching the current filter
There are no more items matching the current filter
Back to top